Literature DB >> 11549779

Thrombotic complications of central venous catheters in cancer patients.

M Monreal1, E Davant.   

Abstract

Today many patients with cancer have indwelling long-term central venous catheters. Benefits from catheter use include increased ease of administration of either chemotherapy or other drugs. However, these patients are prone to a number of complications, including deep venous thrombosis (DVT) and infection. Two kinds of catheter-related thrombi may develop: sleeve thrombi developing on the outside of intravenous catheters and occlusive DVT. Recent studies have demonstrated that the prevalence of pulmonary embolism in patients with arm DVT is high, and it is close to that observed in cohorts of patients with lower-extremity DVT. Accordingly, some kind of prophylaxis seems to be warranted. Furthermore, patients with confirmed catheter-related DVT should receive long-term anticoagulant therapy. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11549779     DOI: 10.1159/000046591

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  11 in total

1.  Local thrombolytic therapy in cancer patients with central venous catheter occlusion in urgent need of antiblastic treatment: a single institution experience.

Authors:  Alberto Agazzi; Daniele Laszlo; Franco Orsi; Roberto Biffi; Giovanni Martinelli
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

2.  Atypical pulmonary embolism of port catheter fragments in oncology patients.

Authors:  Alexey Surov; Karin Jordan; Michael Buerke; Monica Persing; Bettina Wollschlaeger; Curd Behrmann
Journal:  Support Care Cancer       Date:  2006-01-25       Impact factor: 3.603

Review 3.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

4.  Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.

Authors:  Scott A Irwin; Alana Iglewicz; Richard A Nelesen; Jessica Y Lo; Connie H Carr; Sheilani D Romero; Linda S Lloyd
Journal:  J Palliat Med       Date:  2013-06-27       Impact factor: 2.947

5.  Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases.

Authors:  Alana Iglewicz; Katherine Morrison; Richard A Nelesen; Tingting Zhan; Boris Iglewicz; Nathan Fairman; Jeremy M Hirst; Scott A Irwin
Journal:  Psychosomatics       Date:  2014-06-05       Impact factor: 2.386

6.  Focal FDG Activity in the Region of Right Atrium: Coregistered CT Identifies Three Benign Etiologies.

Authors:  Murali Meka; E Gordon Depuey; Peeyush Bhargava
Journal:  Radiol Case Rep       Date:  2015-11-06

7.  Cardiac Magnetic Resonance for Evaluating Catheter Related FDG Avidity.

Authors:  Daniel Jeong; Kenneth L Gage; Claudia G Berman; Jaime L Montilla-Soler
Journal:  Case Rep Radiol       Date:  2016-10-27

8.  Venous Thromboembolism During Ten-year Follow up on Clinical Center University of Sarajevo.

Authors:  Akif Mlaco; Nejra Mlaco; Demir Bejtovic; Alen Dzubur; Muhamed Spuzic
Journal:  Mater Sociomed       Date:  2019-06

9.  Central venous port system associated thromboses: outcome in 3498 implantations and literature review.

Authors:  Martina Schumacher; Roland H Wagner
Journal:  Ger Med Sci       Date:  2007-09-03

10.  Congenital and acquired thrombotic risk factors in lymphoma patients bearing upper extremities deep venous thrombosis: a preliminary report.

Authors:  Pierpaolo Di Micco; Alferio Niglio; Amalia De Renzo; Anna Lucania; Rosanna Di Fiore; Olga Scudiero; Giuseppe Castaldo
Journal:  J Transl Med       Date:  2004-03-22       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.